Economic evaluation of collagenase-containing ointment and hydrocolloid dressing in the treatment of pressure ulcers

• Published in: PharmacoEconomics Vol. 19; no. 12; pp. 1209 - 1216
• Main Authors: MÜLLER, Elvira, VAN LEEN, Martin W. F, BERGEMANN, Rito
• Format: Journal Article
• Language: English
• Published: Auckland Adis International 01.01.2001; Springer Healthcare | Adis
• Series: PharmacoEconomics
• Subjects: Aged; Bandages, Hydrocolloid; Biological and medical sciences; Collagenase; Collagenases - economics; Collagenases - therapeutic use; Colloids - economics; Colloids - therapeutic use; Cost analysis; Cost-Benefit Analysis; Female; Health technology assessment; Hospitalization - economics; Humans; Hydrocolloid occlusive dressing; Medical sciences; Netherlands; Ointments; Pharmacoeconomics; Pharmacology. Drug treatments; Pressure Ulcer - drug therapy; Pressure Ulcer - economics; Skin disorder therapies; Skin ulcer; Skin, nail, hair, dermoskeleton; Wound Healing - drug effects; Netherlands; Europe; Human; Skin disease; Enzyme; Heel; Sore; Metalloendopeptidases; Ointment; Colloidal gel; Peptidases; Dressing; Chemotherapy; Treatment; Health economy; Hydrolases; Skin; Cicatrization; Comparative study; Interstitial collagenase; Public health; Cost efficiency analysis
• ISSN: 1170-7690; 1179-2027
• DOI: 10.2165/00019053-200119120-00003

To evaluate the efficacy and cost effectiveness of two treatments of pressure sores on the heel: a collagenase-containing ointment and a hydrocolloid dressing. Study and cost data were collected prospectively in a randomised clinical trial in The Netherlands by counting the resource use for each patient until wound healing occurred. All 24 female study participants were inpatients from the same hospital with grade IV pressure sores on the heel following orthopaedic surgery. Two different treatment strategies were analysed: a collagenase-containing ointment (Novuxol) and a hydrocolloid dressing (Duoderm). Hospital perspective. The average costs per patient for treatment with the hydrocolloid dressing were about 5% higher than those with the collagenase-containing ointment. The treatment costs were similarly distributed within both groups, with 34% for materials and 66% for personnel. The cost-effectiveness analysis revealed that cost savings of 899 Dutch guilders (1998 values) per successfully treated patient could be expected using the collagenase-containing ointment instead of the hydrocolloid dressing. In addition, wound healing was achieved, on average, within a shorter time period with the collagenase treatment (10 weeks) compared with the hydrocolloid treatment (14 weeks). The robustness of the results were also tested using sensitivity analyses. These analyses served to confirm that collagenase treatment provides a better cost-effectiveness ratio than hydrocolloid treatment. With regard to overall costs and costs per successfully treated patient, this study showed collagenase treatment to be more cost effective than the hydrocolloid treatment in patients with grade IV pressure sores on the heel and that the amount of time needed for wound healing was shorter.